Christine H. Lee

发表

Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis

R. Hunt, Yuhong Yuan, Z. Kassam, 2013, The American Journal of Gastroenterology.

Comparison of the RIDASCREEN norovirus enzyme immunoassay to IDEIA NLV GI/GII by testing stools also assayed by RT-PCR and electron microscopy.

Christine H. Lee, E. Portillo, M. Smieja, 2007, Journal of virological methods.

Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.

Christine H. Lee, F. Smaill, M. Smieja, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

Antonio Ramos, T. V. Van Schooneveld, D. Gerding, 2015, JAMA.

Fever in returning travellers due to a noninfectious disease: Two case reports.

Christine H. Lee, Saul Miller, Kevin Gabel, 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.

Christine H. Lee, E. Carlisle, M. Smieja, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment.

Christine H. Lee, J. Schwalm, P. El-Helou, 2004, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Christine H. Lee, C. Cunningham, 2003, BMC infectious diseases.

debilitating sequelae and can be life threatening

Christine H. Lee, D. Yamamura, N. Rau, 2006 .

S1223 Fecal Transplantation via Retention Enema is Effective for Recurrent or Refractory Clostridium difficile-Associated Diarrhea

J. Marshall, Z. Kassam, Christine H. Lee, 2010 .

Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects.

M. Surette, P. Moayyedi, M. Moshkovich, 2021, Gastroenterology.

Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection

Christine H. Lee, M. Smieja, Kevin Zhang, 2019, BMC Infectious Diseases.

A Practical Method for Preparation of Fecal Microbiota Transplantation.

E. Petrof, Christine H. Lee, Elizabeth Perez, 2016, Methods in molecular biology.

Invasive Bacillus cereus infection in a renal transplant patient: A case report and review.

Christine H. Lee, S. John, J. Neary, 2012, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes

T. Louie, L. Valiquette, S. Gorbach, 2016, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Coccidioides immitis: two cases of misidentified mycosis.

K. Chorneyko, Christine H. Lee, L. Wilcox, 2008, Canadian Respiratory Journal.

A 44-year-old woman with dry cough and solitary nodule.

A. Peregrine, Christine H. Lee, M. Crowther, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Treatment of candiduria with micafungin: A case series.

Christine H. Lee, C. Rotstein, D. Lagrotteria, 2007, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

P. Moayyedi, J. Weese, Yingfu Li, 2016, JAMA.

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

D. Gerding, E. Dubberke, H. Dupont, 2022, BMC Infectious Diseases.

Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection

D. Gerding, E. Dubberke, S. Khanna, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Overwhelming pulmonary infection after a tobogganing accident.

R. Singh, Christine H. Lee, B. Louie, 2005, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

No specific therapy for pulmonary diro- filariasis is required.

A. Peregrine, Christine H. Lee, M. Crowther, 2003 .

Rat-bite Fever, Canada

Christine H. Lee, D. Yamamura, N. Rau, 2006, Emerging infectious diseases.

Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling

M. Surette, S. Collins, P. Bercik, 2016, Genome Medicine.

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

M. Surette, P. Moayyedi, J. Marshall, 2015, Gastroenterology.

Vancomycin-Resistant Enterococcus (VRE) Transmission and Risk Factors in Contacts of VRE Carriers

Christine H. Lee, D. Mertz, Reham M Kaki, 2014, Infection Control & Hospital Epidemiology.

Fecal microbiota transplantation for recurrent Clostridioides difficile infection associates with functional alterations in circulating microRNAs.

T. Yau, D. Lacy, T. Louie, 2021, Gastroenterology.

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

D. Gerding, G. Rahav, M. Wilcox, 2017, New England Journal of Medicine.

Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.

J. Weese, Christine H. Lee, A. Bersenas, 2015, Anaerobe.

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

D. Gerding, Wayne N. Campbell, J. Zenilman, 2017, The Lancet. Infectious diseases.

Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation

Christine H. Lee, S. Jeon, Jocelyn Chai, 2018, Current Infectious Disease Reports.

Association of Medical Microbiology and Infectious Disease Canada treatment practice guidelines for Clostridium difficile infection

P. Moayyedi, T. Louie, L. Valiquette, 2018, Official Journal of the Association of Medical Microbiology and Infectious Disease Canada.

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

D. Gerding, E. Dubberke, G. Rahav, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Review of Management of Clostridium difficile Infection: Primary and Recurrence

Christine H. Lee, Y. Vincent, A. Manji, 2015, Antibiotics.

Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review.

L. Dolovich, Christine H. Lee, Jennifer M Tung, 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Management of Primary and Recurrent Clostridium difficile Infection: An Update

Christine H. Lee, Jocelyn Chai, 2018, Antibiotics.

Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges.

R. Hunt, Z. Kassam, Christine H. Lee, 2014, Clinics in laboratory medicine.

Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.

J. Marshall, Z. Kassam, Christine H. Lee, 2012, Archives of internal medicine.

Building an Adult Congenital Heart Program: Critical Components and Important Allies

Christine H. Lee, T. MacGillivray, Akanksha N Thakkar, 2018, Current Cardiology Reports.

Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections

Jens Praestgaard, Karl Weiss, J. Praestgaard, 2014, Antimicrobial Agents and Chemotherapy.

Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient.

Christine H. Lee, J. Schwalm, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection

T. Louie, D. Gerding, E. Dubberke, 2016, Open forum infectious diseases.

Bezlotoxumab Alone and With Actoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients on Standard of Care Antibiotics: Integrated Results of 2 Phase 3 Studies (MODIFY I and MODIFY II)

D. Gerding, G. Rahav, M. Wilcox, 2015 .

Lack of Association with Patient Demographics and Outcomes in Punch CD 2, a Randomized Controlled Trial of RBX2660, a Microbiota-Based Drug for Recurrent Clostridium Difficile Infection

E. Dubberke, S. Khanna, Christine H. Lee, 2017 .

Navigating Long-Term Safety in Fecal Microbiota Transplantation

R. Hunt, Yuhong Yuan, Z. Kassam, 2013, The American Journal of Gastroenterology.

Precision medicine and gut dysbiosis

Zeny Z. Feng, Christine H. Lee, Dawn N. Waterhouse, 2020, Healthcare management forum.

Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure

Christine H. Lee, S. Jeon, Jocelyn Chai, 2019, European Journal of Clinical Microbiology & Infectious Diseases.

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

Stephen T Rush, Christine H. Lee, J. Weese, 2017, Open Forum Infectious Diseases.

A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics.

G. Gloor, E. Allen-Vercoe, G. Reid, 2012, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial.

T. Louie, Christine H. Lee, K. Mullane, 2016, The Journal of antimicrobial chemotherapy.

Fecal transplantation for recurrent or refractory Clostridium difficile diarrhea

J. Marshall, Z. Kassam, Christine H. Lee, 2011 .

RBX2660 is Safe, Superior to Antibiotic-Treated Controls for Preventing Recurrent Clostridium difficile, and May Rehabilitate Patient Microbiomes: Open Label Trial Results

E. Dubberke, H. Dupont, S. Khanna, 2017 .

Microbiome Profile is Distinct in Patients with Successful Response to Microbiota-Based Drug RBX2660 Relative to Placebo Responders

D. Gerding, E. Dubberke, S. Khanna, 2017 .

Efficacy and Safety of RBX2660 for the Prevention of Recurrent Clostridium difficile Infection: Results of the PUNCH CD 2 Trial

E. Dubberke, J. Fraiz, S. Khanna, 2016 .

Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review.

L. Dolovich, Christine H. Lee, Jennifer M Tung, 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Comparison of Clostridium difficile isolates from individuals with recurrent and single episode of infection.

Christine H. Lee, A. Bersenas, P. Kim, 2015, Anaerobe.

Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial.

T. V. Van Schooneveld, D. Gerding, D. Pardi, 2015, JAMA.

Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges.

R. Hunt, Z. Kassam, Christine H. Lee, 2014, Clinics in laboratory medicine.

An elderly man with nonresolving cough, leukocytosis and a pulmonary mass.

S. Pugsley, Christine H. Lee, M. Smieja, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.